Clinical trial
Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous…
NCT00006431 · National Center for Research Resources (NCRR), NIH · Unknown status
Key facts
| NCT number | NCT00006431 |
|---|---|
| Title | Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | Duke University |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Renal Cell Carcinoma |
| Intervention type | Biological |
| Interventions | DC RCC-RNA |
| First posted | Nov 6, 2000 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: